網龍/金山軟件/新東方在線反覆續吐6%-7%
雖然內地「新冠肺炎」疫情確診個案最新已累增至42,638宗,死亡人數增至1,016宗。不過,憧憬行業需求增近日股價持續舞高探頂的中港在線教育、網上辦公及雲服務等相關概念股高位終遇壓,尤其是過去一個月股價累積升幅近88%的新東方在線(01797.HK)由紀錄高位反覆連吐第二天,最高見38.5元,現造32.9元,反覆續吐7.3%,成交增至1,940萬股。
網龍(00777.HK)由近兩年半高位連吐第二天,最高見28.2元,現造25.55元,反覆續吐5.9%;金山軟件(03888.HK)由近兩年高位連吐第二天,最高見28.95元,現造26.6元,反覆續吐6%,成交增至3,101萬股。(sz/t)~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.